Where Do We Stand With Mifepristone in the United States?: Making Sense of the Madness
- PMID: 37225395
- DOI: 10.1097/AOG.0000000000005253
Where Do We Stand With Mifepristone in the United States?: Making Sense of the Madness
Conflict of interest statement
Financial Disclosure The author did not report any potential conflicts of interest.
References
-
- U.S. Food and Drug Administration. Information about mifepristone for medical termination of pregnancy through ten weeks gestation. Accessed May 8, 2023. https://www.fda.gov/drugs/postmarket-drug-safety-information-patients-an...
-
- Medication abortion up to 70 days of gestation. ACOG Practice Bulletin No. 225. American College of Obstetricians and Gynecologists. Obstet Gynecol 2020;136;e31–47. doi: 10.1097/AOG.0000000000004082 - DOI
-
- Kapp N, Eckersberger E, Lavelanet A, Rodriguez MI. Medical abortion in the late first trimester: a systematic review. Contraception 2019;99:77–86. doi: 10.1016/j.contraception.2018.11.002 - DOI
-
- World Health Organization. Medical management of abortion. Accessed May 8, 2023. https://apps.who.int/iris/bitstream/handle/10665/278968/9789241550406-en...
-
- Jones RK, Kirstein M, Philbin J. Abortion incidence and service availability in the United States, 2020. Perspect Sex Reprod Health 2022;54:128–141. doi: 10.1363/psrh.12215 - DOI
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
